ENOV (Enovis) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 24, 2026)


ENOV Enovis Corp ENOV
61 GF Score
Price $21.31
GF Value $49.60
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Enovis's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ENOV vs IART, AHCO, ALMR: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Enovis's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enovis Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Enovis's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Enovis's Margin of Safety % (DCF Earnings Based) falls into.


ENOV
61GF Score
Enovis Corp ENOV
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $21.31 is trading 57% below its estimated GF Value™ of $49.60. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $49.60 vs. price of $21.31 (57% below fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
61GF Score

Get the complete analysis for ENOV

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.31
Price
$49.60
GF Value